Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells.

International journal of oncology

Volumn 21, Issue 1, 2002, Pages 207-211

  El Rayes, Basil F ^a   Grignon, Robert ^a   Aslam, Naveed ^a   Aranha, Olivia ^a   Sarkar, Fazlul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BAX PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CIPROFLOXACIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; ETOPOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIVISION; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; RADIATION DOSE;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL DIVISION; CIPROFLOXACIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOWN-REGULATION; DRUG SYNERGISM; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ETOPOSIDE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; NF-KAPPA B; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 0036653128     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.21.1.207     Document Type: Article

References (0)